SCHEMBL25530657

SCHEMBL25530657

COC(=O)c1cccc(CN(CC=O)C(=O)c2ccc(-c3ccnc(N)c3)cc2N(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.38
ROCK1 Q13464 6/20 0.38
CYP3A4 P08684 2/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
PRKACA P17612 1/20 0.38
CYP4F2 P78329 2/20 0.37
CYP4A11 Q02928 2/20 0.37
SLC7A5 Q01650 1/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MPO P05164 1/20 0.36
ERN1 O75460 1/20 0.36
GSK3B P49841 1/20 0.35
CSF1R P07333 2/20 0.35
NPC1 O15118 1/20 0.35
CYP2D6 P10635 1/20 0.35
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25530669 0.91 AOC3 (0.36) ROCK2ROCK1CYP3A4LOXL2PRKACA
SCHEMBL25530684 0.82 ROCK2 (0.43) ROCK2ROCK1GSK3B
SCHEMBL25530645 0.81 CYP4F2 (0.43) LOXL2CYP4F2CYP4A11SLC7A5RAB9A
SCHEMBL3124357 0.72 LOXL2 (0.55) LOXL2CYP4F2CYP4A11SLC7A5RAB9A
SCHEMBL12393362 0.67 LOXL2 (0.48) LOXL2CYP4F2CYP4A11SLC7A5RAB9A
SCHEMBL5542944 0.66 MKNK1 (0.67) ROCK2ROCK1CYP3A4RAB9ASMN1; SMN2
SCHEMBL25529426 0.66 CIT (0.34) ROCK2ROCK1CYP3A4CYP2D6
SCHEMBL25529417 0.66 CIT (0.33) ROCK2ROCK1CYP3A4CYP2D6
SCHEMBL25529526 0.64 TRPM8 (0.44) ROCK2ROCK1
SCHEMBL165622 0.64 LOXL2 (0.66) LOXL2CYP4F2CYP4A11SLC7A5RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed